Tirzepatide 5,41mg Pen

Weight loss

Tirzepatide 5,41mg Pen

R 2848.00 Incl. VAT

Cold-chain shipped

Price Includes

  • Doctor's Consultation
  • Prescription Fee
  • Dispensing Fee
  • Compounding Fee
  • Administration Fee
  • Processing
  • Professional & Service Fees

Excludes

  • Cost of Blood Tests
Doctor-reviewedSA lab compoundedDiscreet shipping

Indications

Tirzepatide is a dual GIP and GLP-1 receptor agonist prescribed for medically supervised weight management in patients who meet clinical criteria, always alongside diet and activity support.

Product description

A pre-filled, multi-dose pen holding 21,66 mg of tirzepatide in 2,6 ml — the entry strength of the tirzepatide range. Compounded and dispensed by a licensed South African pharmacy after a doctor reviews your intake.

Weight lossFat lossAppetite controlTirzepatide

Common questions

Clinical information

Benefits

  • Acts on both GIP and GLP-1 receptors, which reduces appetite and slows gastric emptying
  • Once-weekly dosing from a single pre-filled pen with no mixing or reconstitution
  • The lowest strength in the range, used while your doctor titrates you upward

Contraindications

  • Personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome type 2
  • A history of pancreatitis
  • Pregnancy, breastfeeding or planning pregnancy

Key interactions

  • Insulin and sulfonylureas — additive glucose lowering and hypoglycaemia risk
  • Oral medicines whose absorption depends on gastric emptying time

Risk & side effects

  • Nausea, vomiting and diarrhoea, most common during dose increases
  • Constipation, reflux and abdominal discomfort
  • Marked appetite loss, which can lead to low protein intake and muscle loss without supervision

This information is educational and does not replace professional medical advice. Your prescribing doctor reviews your full medical profile before any treatment is approved.

1